Tuesday, October 20, 2020
Home Life Style Health & Fitness Philadelphia Jury Awards $8 Billion in Punitive Damages against Johnson & Johnson

Philadelphia Jury Awards $8 Billion in Punitive Damages against Johnson & Johnson

Johnson and Johnson immediately denounced the award after the jury's decision in the Court of Common pleas, saying it's "excessive and unfounded"

A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff’s attorneys say is linked to the abnormal growth of female breast tissue in boys.

Johnson and Johnson immediately denounced the award after the jury’s decision in the Court of Common pleas, saying it’s “excessive and unfounded” and vowing immediate action to overturn it.

The antipsychotic drug Risperdal is at the center of the lawsuit, with the plaintiff’s attorneys arguing it’s linked to abnormal growth of female breast tissue in boys, an incurable condition known as gynecomastia.

Johnson & Johnson used an organized scheme to make billions of dollars while illegally marketing and promoting the drug, attorneys Tom Kline and Jason Itkin said in a statement.

Philadelphia, Jury, Damages
A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made. Pixabay

Kline and Itkin said that Johnson & Johnson was “a corporation that valued profits over safety and profits over patients.” Thousands of lawsuits have been filed over the drug, but the attorneys said this was the first in which a jury decided whether to award punitive damages and came up with an amount.

Johnson & Johnson said in a statement on its website it was confident that the award would be overturned, calling it “grossly disproportionate” with the initial compensatory damage award and “a clear violation of due process.”

Johnson & Johnson said the court’s exclusion of key evidence left it unable to present a meaningful defense, including what they said was a drug label that “clearly and appropriately outlined the risks associated with the medicine” or Risperdal’s benefits for patients with serious mental illness. They also said the plaintiff’s attorneys failed to present any evidence of actual harm.

Also Read- Three Scientists Win Nobel Prize in Chemistry for their Contributions to Development of Lithium-Ion Batteries

“This decision is inconsistent with multiple determinations outside of Philadelphia regarding the adequacy of the Risperdal labeling, the medicine’s efficacy, and findings in support of the company,” Johnson & Johnson said. “We will be immediately moving to set aside this excessive and unfounded verdict.” (VOA)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,782FollowersFollow

Most Popular

Air Pollution Causes Food Delivery Leading to Plastic Waste

When the air quality outside is bad, office workers are more likely to order food than go out for lunch, which in turn increases...

Virus Can Reinfect COVID Patients When Antibodies Start Depleting

Patients who have recovered from COVID-19 can again get infected by the virus once the antibodies of the viral disease start depleting, the Indian...

International Chef Day a Low-Key Event Due to Pandemic

The International Chef Day is observed on October 20, but this year, the celebrations here were muted as chefs are facing a torrid time...

Coffee Before Breakfast May Increase Diabetes Risk

If you're taking coffee before breakfast, read this carefully. Researchers have found that drinking coffee first thing can have a negative effect on blood...

India’s Nutrition Experts on Supporting Public Health Delivery

Indias public health and nutrition efforts are differentiated by an enterprising early start going as far back as 1975 with the beginning of Anganwadi...

‘Fashion Reboot’- A Collection Focusing Gen Z

The final day of the digital edition of Lotus Make-up India Fashion Week, Spring/Summer 2021 on Sunday opened a film presentation that showcased a...

Disorder in Sleep Cycle Due to Excessive Use of Cellphones

Cell phones have become integral to function for nearly everyone. While it has brought a lot of tasks to our fingertips, cell phones also...

Higher Mortality Risk for COVID Patients with Kidney Diseases

Researchers, including one of Indian-origin, have found that there is a much higher risk of mortality faced by COVID-19 patients in intensive care, who...

Recent Comments